18,569 Shares in National Health Investors Inc (NHI) Purchased by MetLife Investment Advisors LLC

MetLife Investment Advisors LLC purchased a new stake in National Health Investors Inc (NYSE:NHI) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 18,569 shares of the real estate investment trust’s stock, valued at approximately $1,400,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Eqis Capital Management Inc. grew its position in shares of National Health Investors by 9.5% in the 4th quarter. Eqis Capital Management Inc. now owns 8,050 shares of the real estate investment trust’s stock valued at $607,000 after buying an additional 698 shares during the last quarter. Raymond James & Associates grew its position in shares of National Health Investors by 14.8% in the 4th quarter. Raymond James & Associates now owns 7,379 shares of the real estate investment trust’s stock valued at $556,000 after buying an additional 951 shares during the last quarter. Aperio Group LLC grew its position in shares of National Health Investors by 7.1% in the 4th quarter. Aperio Group LLC now owns 16,495 shares of the real estate investment trust’s stock valued at $1,243,000 after buying an additional 1,092 shares during the last quarter. Swiss National Bank grew its position in shares of National Health Investors by 1.9% in the 4th quarter. Swiss National Bank now owns 69,820 shares of the real estate investment trust’s stock valued at $5,263,000 after buying an additional 1,300 shares during the last quarter. Finally, LPL Financial LLC grew its position in shares of National Health Investors by 45.9% in the 4th quarter. LPL Financial LLC now owns 5,009 shares of the real estate investment trust’s stock valued at $378,000 after buying an additional 1,575 shares during the last quarter. Hedge funds and other institutional investors own 71.83% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other news, VP John L. Spaid purchased 500 shares of the company’s stock in a transaction that occurred on Thursday, February 22nd. The shares were acquired at an average cost of $64.95 per share, with a total value of $32,475.00. Following the purchase, the vice president now owns 971 shares in the company, valued at $63,066.45. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO D. Eric Mendelsohn purchased 2,000 shares of the company’s stock in a transaction that occurred on Thursday, February 22nd. The shares were purchased at an average cost of $65.47 per share, for a total transaction of $130,940.00. Following the completion of the purchase, the chief executive officer now owns 10,580 shares in the company, valued at approximately $692,672.60. The disclosure for this purchase can be found here. Insiders bought a total of 2,812 shares of company stock worth $183,910 over the last three months. 5.19% of the stock is owned by company insiders.

Shares of NYSE:NHI opened at $67.82 on Friday. The stock has a market capitalization of $2,817.54, a PE ratio of 12.72, a price-to-earnings-growth ratio of 3.49 and a beta of 0.43. The company has a debt-to-equity ratio of 0.87, a quick ratio of 13.85 and a current ratio of 13.85. National Health Investors Inc has a 1 year low of $62.71 and a 1 year high of $81.60.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.33 by ($0.43). The business had revenue of $71.06 million during the quarter, compared to analyst estimates of $71.36 million. National Health Investors had a net margin of 57.19% and a return on equity of 12.20%. equities research analysts forecast that National Health Investors Inc will post 5.5 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Stockholders of record on Friday, March 30th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.90%. This is an increase from National Health Investors’s previous quarterly dividend of $0.95. The ex-dividend date of this dividend is Wednesday, March 28th. National Health Investors’s payout ratio is currently 75.05%.

A number of equities research analysts have commented on NHI shares. Stephens set a $79.00 price target on National Health Investors and gave the company a “buy” rating in a research report on Friday, January 12th. Stifel Nicolaus set a $76.00 price target on National Health Investors and gave the company a “buy” rating in a research report on Saturday, February 17th. Hilliard Lyons upgraded National Health Investors from a “neutral” rating to a “buy” rating in a research report on Friday, February 16th. BMO Capital Markets set a $70.00 price target on National Health Investors and gave the company a “hold” rating in a research report on Monday, March 26th. Finally, Mizuho reiterated a “hold” rating and issued a $70.00 price target on shares of National Health Investors in a research report on Monday, February 26th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $76.50.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3340162/18569-shares-in-national-health-investors-inc-nhi-purchased-by-metlife-investment-advisors-llc.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analysts Set Varonis Systems Ltd.  Price Target at $61.50
Analysts Set Varonis Systems Ltd. Price Target at $61.50
Brokerages Set Francesca’s Holdings Corp  Price Target at $6.75
Brokerages Set Francesca’s Holdings Corp Price Target at $6.75
AltaGas  Sets New 1-Year Low at $25.37
AltaGas Sets New 1-Year Low at $25.37
Weir Group  Declares Dividend of GBX 29
Weir Group Declares Dividend of GBX 29
Glencore  to Issue Dividend of $0.10
Glencore to Issue Dividend of $0.10
Eurocell PLC  Increases Dividend to GBX 6 Per Share
Eurocell PLC Increases Dividend to GBX 6 Per Share


Leave a Reply

© 2006-2018 Ticker Report. Google+.